Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

El, Jurdi, N; Holtzman, NG; Hishmeh, R; Mina, A; Schulz, E; Stokes, A; Li, G; Schmidt, KT; Figg, WD; Micheletti, N; Mays, JW; Cowen, EW; Pavletic, SZ; Pusic, I.
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned.
Br J Haematol. 2025; Doi: 10.1111/bjh.20069
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz

Schulz Eduard

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (Keywords)

allogeneic haematopoietic cell transplantation

chronic graft-versus-host disease

front-line treatment

ibrutinib

© Med Uni Graz • Impressum